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Abstract
Background: Respiratory failure, infections and aspiration pneumonia, are the main causes of morbidity and
mortality in Amyotrophic Lateral Sclerosis (ALS). In a population-based cohort, we assessed (a) hospital utilization
and (b) impact of hospitalization for respiratory failure on survival.
Methods: All patients with incident ALS in Friuli Venezia Giulia region, Italy, from 2002 to 2009, were identified
through multiple sources. Diagnosis was validated through clinical documentation review. For each patient, we
extracted the records of all hospitalizations after ALS diagnosis from the regional hospitalization database. Cox
proportional hazards model survival Hazard Ratio (HR), with 95 % Confidence Interval (95 % CI), was calculated.
Results: Out of 262 patients, 98.1 % had at least 1 and 58.0 % ≥3 hospitalizations. Emergency admissions occurred
in 77.5 % of patients and a diagnosis of respiratory failure in 55.0 %. Patients underwent a total of 885 hospitalizations.
The leading diagnosis was respiratory failure (31.6 % of hospitalizations). This diagnosis occurred most frequently in
emergency (45.6 %) than in elective admissions (26.4 %). The second leading diagnosis was pneumonia (14.2 %), 24.9
and 6.3 % respectively. The leading procedure was mechanical ventilation (18.4 %), performed in 29.9 % of emergency
and in 12.4 % of elective admissions. After adjustment for site of onset, age and diagnostic delay, a first hospitalization
for respiratory failure had a strong adverse effect on survival (HR 4.00; 95 % CI 3.00; 5.34).
Conclusions: Respiratory failure, pneumonia and aspiration pneumonia were major determinants of hospitalizations
and emergency admissions and often dealt with in emergency admissions. A first hospitalization for respiratory failure
had a strong adverse effect on survival. Strategies to improve home management of respiratory conditions in patients
with ALS and to optimize hospital care utilization are needed.
Keywords: Amyotrophic Lateral Sclerosis, Hospital utilization, Hospitalization, Respiratory failure, Non-invasive
ventilation, Tracheostomy, Mechanical ventilation, Survival, Cohort studies, Database research
Background
During the course of disease, patients with Amyotrophic
Lateral Sclerosis (ALS) experience a progressive loss of
muscular function leading invariably to disability, paraly-
sis and death. In European population-based studies,
median survival time was between 25 and 30 months
from disease onset [1]. Respiratory failure and compli-
cations such as infections and aspiration pneumonia
are the main causes of morbidity and mortality. Re-
spiratory function is strongly related to ALS outcome
[2]. In the early phase of disease, Sniff Nasal Inspiratory
Pressure is a strong predictor of death or tracheos-
tomy within 1 year of follow-up [3]. Decreased Forced
Vital Capacity due to muscle weakness has been asso-
ciated with an increased risk of short-term mortality
[4]. In patients with early respiratory failure, non-
invasive ventilation (NIV) is recommended [5, 6].
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NIV prolongs survival and may improve patients’
quality of life [7]. Recommendations include advance
directives and planning of respiratory failure manage-
ment to avoid emergency invasive ventilation [5]. In-
vasive mechanical ventilation can prolong survival but
has uncertain impact on the quality of life of patients
and caregivers [5, 8]. The prevalence of invasive ven-
tilation varies greatly between countries [9] and
within Italy from 10.6 % [10] to 24.5 % [11], as re-
ported by population-based studies.
Hospital care utilization is common in patients with
ALS and represents the third main contributor to costs
of care, after home care and ventilation [12]. The pro-
portion of patients hospitalized decreased from 80 % in
2000 to less than 40 % in 2012 [13]. Evaluating hospital
admissions with a diagnostic code for ALS in large US
administrative databases, two studies reported that
emergency admissions were common while only about
20 % were elective [14, 15]. The main reasons for
hospitalization were respiratory failure and pneumonia.
Patients admitted for respiratory failure showed a 5-
fold increased risk of dying in hospital (odds ratio of
death: 5.03; 95 % CI 4.57–5.54); in-hospital mortality
was 25.4 % in the subgroup undergoing CPAP/BiPAP
and 30 % in the subgroup undergoing mechanical ven-
tilation ˂96 h [14].
In other respiratory diseases such as idiopathic pul-
monary fibrosis, early and respiratory-related hospital
admissions have been associated with increased all-
cause mortality [16]. In patients with ALS, the effect of
hospitalizations for respiratory conditions on overall
survival has not been evaluated.
Several studies suggest that the modality of health
care provision for patients with ALS has a relevant
impact on quality of life and use of healthcare facil-
ities. Patients followed up by multidisciplinary centers
had lower in-hospital mortality and shorter length of
stay [10]. Community care management and coordin-
ation led to a decrease in overall and emergency non-
planned hospitalizations [13]. Telemonitoring of home
NIV reduced hospital admissions and emergency room
visits [17].
This population-based cohort study of incident ALS
cases in Friuli Venezia Giulia (FVG) region, Northeastern
Italy, from 2002 to 2009, aims to assess: (a) hospitaliza-
tions after the diagnosis of ALS, focusing on admissions
and procedures related to respiratory problems and (b)
the impact of hospitalizations for respiratory failure on
survival.
Methods
Study population
The study was conducted in FVG resident population,
approximately 1,200,000 inhabitants [18].
Data sources
All FVG residents are registered with the Regional
Health System, providing universal access to care.
Their use of health services is registered in computer-
ized databases. Anonymized individual records can be
linked by a unique personal identifier. For this study
the database of hospitalizations was used. This data-
base records data of all hospitalizations of residents
in hospitals of FVG and of other Italian regions. Day-
hospital admissions, where the patient was admitted
and discharged within 24 h, are also included. For
each hospitalization, the following information is reg-
istered: dates of admission and discharge, type of ad-
mission (emergency, elective or day hospital), one
primary and up to five secondary discharge diagnostic
codes and up to six codes for procedures, if
hospitalization ended with death and date of death.
Emergency admissions are those not planned in ad-
vance but occurring abruptly due to clinical need.
Diagnoses and procedures are coded according to the
International Classification of Diseases, ninth revision,
clinical modification (ICD-9-CM) coding system.
Study cohort
The cohort included any resident with an incident diag-
nosis of ALS from January 1st, 2002 to December 31,
2009. The ascertainment of cases has been described
elsewhere [19]. Multiple sources, including database of
hospitalizations, electronic medical records and archives
of Neurology departments, were used to detect patients
diagnosed during in- or out-patient medical encounters.
ALS diagnosis was validated through clinical documen-
tation review. For each detected case, four neurologists
independently reviewed clinical documentation for any
hospitalization or relevant healthcare encounter up to
December 31, 2009, to confirm the diagnosis. ALS con-
firmation was based on information relative to the entire
follow-up and required the following criteria to be met:
(a) ALS diagnosis explicitly written by a neurologist and/
or (b) prescription for Riluzole in the therapeutic plan.
All patients with confirmed ALS and a diagnosis of pos-
sible, probable or definite ALS according to El Escorial
criteria [20, 21] were included.
Data collection
Information on date of diagnosis and site of onset
was abstracted from clinical documentation. The date
of diagnosis was defined as (a) the date of discharge
when ALS was diagnosed or confirmed during a
hospitalization (the diagnosis was written by the physician
on the discharge letter) or (b) the date of the examination,
when ALS was diagnosed during an outpatient exam-
ination. We extracted the records of all hospitaliza-
tions from January 1st, 2000 to December 31, 2011,
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information on residential history (to account for po-
tential emigration from the region) and date of death,
up to December 31, 2011.
Hospitalizations after the diagnosis of ALS where
those with date of admission after the date of diagno-
sis. Vital status of patients at the end of follow-up
(December 31, 2011) was ascertained through record
linkage with the mortality database.
Statistical analysis
Taking the patient as statistical unit, we performed a de-
scriptive analysis of their characteristics and hospitaliza-
tions according to ALS site of onset. Frequencies were
compared through the chi square test. Kaplan Mayer
product-limit survival function was used to calculate
survival times, overall and after the first hospitalization
(a) for respiratory failure, both as primary or any sec-
ondary code, (b) tracheostomy or (c) mechanical ventila-
tion (MV).
Survival Hazard Ratios (HR), with 95 % Confidence
Interval (95 % CI), were calculated through Cox propor-
tional hazards model. The following terms were assessed
in univariate analysis: having a first hospitalization for
respiratory failure after the diagnosis of ALS, type of on-
set, sex, age at disease onset, diagnostic delay (lag
time between the onset of symptoms and diagnosis),
Charlson Comorbidity Index and having a hospitalization
for respiratory failure before the diagnosis of ALS.
The first hospitalization for respiratory failure after
the diagnosis of ALS was defined as the first
hospitalization after the date of diagnosis with one of
the following primary or any secondary ICD-9-CM
codes: 518.81 acute respiratory failure, 518.83 chronic
respiratory failure, 518.84 acute on chronic respiratory
failure and 518.82 unidentified respiratory failure.
This variable was time‐dependent and was therefore
included in the model using the counting process
method [22].
A hospitalization for respiratory failure before the
diagnosis of ALS was defined as occurred any time be-
fore the date of diagnosis with one of the above reported
primary or any secondary ICD-9-CM codes.
Taking the hospitalization as the statistical unit, we
performed a descriptive analysis of diagnoses and proce-
dures according to the type of admission (emergency,
elective or day-hospital).
Statistical analysis was performed using SAS© statistical
package 9.2 (SAS Institute Inc., Cary, N.C., USA).
Results
A total of 262 patients, 50.4 % men, 49.6 % aged ≥ 68 years
at diagnosis, were identified (Table 1). The site of onset
was spinal in 50.7 % and bulbar in 34.0 %. Information on
the site of onset was missing in 15.3 % (N = 40).
Four patients died during the hospitalization where the
diagnosis was made and were excluded from the analysis.
Only one patient did not have any hospitalization after the
diagnosis, 98.1 % (N = 257) were hospitalized at least once
after the diagnosis and 58.0 % three or more times. More
than 75.0 % had at least one emergency admission and
41.2 % two or more.
More than 50 % were hospitalized at least once for
respiratory failure and 45.0 % for acute respiratory fail-
ure. Hospitalizations for respiratory failure were more
common in patients with bulbar onset (58.4 %), than in
those with spinal (54.9 %) or unknown (47.5 %) onset
(p = 0.02). One third of patients underwent MV, more
frequently those with spinal onset (40.6 %) than with
bulbar (23.6 %) or unknown onset (30.0 %) (p = 0.03).
Overall, 22.9 % underwent tracheostomy, more fre-
quently those with spinal onset (27.8 %). Only 11.1 %
(N = 29) underwent in-hospital NIV.
By the end of follow-up, 81.7 % of patients were de-
ceased; 53.3 % of them died in hospital. During follow-
up, the cohort had 885 hospitalizations (Table 2).
Emergency admissions accounted for 47.6 %. Median
length of stay was 8 days (Inter Quartile Range IRQ 4;
15) in elective and 8 days (IQR 4; 17) in emergency
admissions (data not shown).
Respiratory failure was the most common discharge
diagnosis, occurring as primary code in 19.4 % and in
any position in 31.6 % hospitalizations, followed by
pneumonia (5.5 and 14.2 %, respectively) and aspiration
pneumonia (1.0 and 2.1 %, respectively).
Respiratory failure, acute respiratory failure and pneu-
monia were more frequent in emergency admissions, oc-
curring as primary and/or secondary code in 45.6, 32.8
and 24.9 % hospitalizations, respectively. Conversely,
acute respiratory failure or pneumonia were uncommon
in day hospital admissions (each 1.2 %). Aspiration
pneumonia occurred almost exclusively in emergency
admissions.
More than 80 % of the 114 patients who died in hos-
pital, died in emergency hospitalizations. In hospitaliza-
tions ending with death, respiratory failure (58.8 %) and
diseases of the respiratory system (43.9 %) were the most
common codes (Additional file 1: Table S1).
The most common procedure was MV, performed
in 18.4 % hospitalizations and more frequently
(13.2 %) lasting ≥96 h, followed by tracheostomy
(7.1 %) and NIV (3.9 %) (Table 3). MV was more
common in emergency (29.9 %) than in elective
(12.4 %) admissions, as well as NIV (5.0 % vs. 2.0 %)
and tracheostomy (12.6 % vs. 3.3 %). Conversely, gastro–
or entero–stomies were performed more frequently in
elective (13.0 %) admissions.
Diagnostic procedures, such as electromyography
(12.6 %) and magnetic resonance imaging (MRI) (6.8 %),
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Table 1 Number and distribution of patients with ALS by selected characteristics and hospitalizations after the diagnosis of ALS
aChi square test p comparing proportions between patients with bulbar, spinal and unknown site of onset
bExcludes one patient who did not have any hospitalization after the diagnosis of ALS and four patients who died during the hospitalization in which the
diagnosis of ALS was made
cAt least one hospitalization after the diagnosis of ALS with discharge code for respiratory failure (ICD-9-CM codes 518.81, 518.82, 518.83, 518.84) in any position
dSubtotal of patients with at least one hospitalization with discharge code for respiratory failure
eSubtotal of patients with at least one hospitalization with discharge code for acute respiratory failure
fDead or alive at the end of follow up, December 31, 2011
gThe denominator of percentages is the total number of deceased patients
Table 2 Number and distribution of the most common discharge diagnoses, by type of admission
Type of admission
Emergency
(N = 421)
Elective
(N = 299)
Day hospital
(N = 165)
Overall
(N=885)
Discharge diagnosis (ICD-9-CM codes) Primary codea Any codeb Primary codea Any codeb Primary codea Any codeb Primary codea Any codeb
N (%) N % N % N % N % N % N % N %
ALS (335.20) 112 (26.6) 335 (79.6) 154 (51.5) 233 (77.9) 122 (73.9) 132 (80.0) 388 (43.8) 700 (79.1)
Respiratory failure (518.81-.84) 117 (27.8) 192 (45.6) 49 (16.4) 79 (26.4) 6 (3.6) 9 (5.4) 172 (19.4) 280 (31.6)
Acute (518.81) 93 (22.1) 138 (32.8) 44 (14.7) 59 (19.7) - 2 (1.2) 137 (15.5) 199 (22.5)
Chronic (518.83) 3 (0.7) 9 (2.1) 2 (0.7) 15 (5.0) 6 (3.6) 6 (3.6) 11 (1.2) 30 (3.4)
Acute on chronic (518.84) 12 (2.8) 25 (5.9) 1 (0.3) 2 (0.7) - - 13 (1.5) 27 (3.0)
Unidentified (518.82) 9 (2.1) 21 (5.0) 2 (0.7) 3 (1.0) - 1 (0.6) 11 (1.2) 25 (2.8)
Diseases of the respiratory system (460-519) 71 (16.9) 156 (37.0) 7 (2.3) 30 (10.0) - 5 (3.0) 78 (8.8) 191 (21.6)
Pneumonia and influenza (480-487) 44 (10.4) 105 (24.9) 5 (1.7) 19 (6.3) - 2 (1.2) 49 (5.5) 126 (14.2)
Aspiration pneumonia (507.0) 10 (2.4) 18 (4.3) - 1 (0.3) - - 10 (1.1) 19 (2.1)
aNumber and percentage (%) of hospitalizations with the corresponding discharge diagnosis as primary code
bNumber and percentage (%) of hospitalizations with the corresponding discharge diagnosis as primary or any secondary code
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were most common in day-hospital admissions (29.7
and 17.6 %, respectively).
The overall median survival of the entire cohort was
20.5 months (95 % CI 17.2; 24.9) (Fig. 1). After the first
hospitalization for respiratory failure, median survival
time was 8.0 months (95 % CI 3.1; 13.2) and after the
first hospitalization with MV 9.7 months (95 % CI
4.1–18.2).
The first hospitalization with diagnosis of respiratory
failure occurred on average 32.2 months (Standard
Deviation SD 2.0; median 23.8 months) and with MV
21.0 months (SD 1.9; median 15.8 months) after the
diagnosis (data not shown).
When simultaneously adjusting for site of onset, age
and diagnostic delay, the first hospitalization for respira-
tory failure was associated with a fourfold increased risk
of death (HR 4.00, 95 % CI 3.00; 5.34) (Table 4). Adding
a term for Charlson Index or hospitalizations before
diagnosis (a total of 16 patients were hospitalized before
diagnosis) did not change the results (Additional file 1:
Table S2).
Discussion
In our population-based cohort, almost all ALS patients
were hospitalized at least once and more than 75 % twice
or more. More than half of patients were hospitalized at
least once for respiratory failure, mostly acute. Among all
hospitalizations, respiratory failure was the leading dis-
charge diagnosis, followed by other respiratory conditions
and pneumonia including aspiration pneumonia. These
results are consistent with those reported by two studies
evaluating hospital admissions with a diagnostic code for
ALS in US administrative databases [14, 15]. Respiratory
failure and other respiratory conditions were more fre-
quent in emergency than in elective admissions. Emer-
gency admissions were common in patients with ALS:
between 40 and 54 % of patients were admitted through
the emergency room [14, 15, 23].
Table 3 Number and distribution of procedures, by type of admission
Procedures (ICD-9-CM codes) a Type of admission Overall
(N = 885)Emergency
(N = 421)
Elective
(N = 299)
Day hospital
(N = 165)
N % N % N % N %
Respiratory function
Mechanical ventilation (96.7–96.72) 126 29.9 37 12.4 - - 163 18.4
≥ 96 h (96.72) 93 22.1 24 8.0 - - 117 13.2
< 96 h (96.71) 17 4.0 4 1.3 - - 21 2.3
Unspecified duration 16 3.8 9 3.0 - - 25 2.8
Tracheostomy (31.1–31.2) 53 12.6 10 3.3 - - 63 7.1
Non invasive ventilation (93.90) 21 5.0 6 2.0 8 4.8 35 3.9
IPPB (93.91) 6 1.4 7 2.3 - - 13 1.5
Other respiratory therapy (93.94, 93.96, 93.97, 93.99) 43 10.2 8 2.7 - - 51 5.8
Measurement of arterial blood gases (89.65) 79 18.8 40 13.3 7 4.2 126 14.2
Nutrition
Gastro- or entero- stomy 40 9.5 39 13.0 7 4.2 86 9.7
PEGb (43.11) 32 7.6 29 9.6 7 4.2 68 7.6
PEJc (46.32) 5 1.1 6 2.0 - - 11 1.2
Other gastrostomy (43.19) 3 0.7 4 1.3 - - 7 0.7
Diagnostic procedures
Electromyography (93.08) 16 3.8 47 15.7 49 29.7 112 12.6
MRId of brain, brain stem and spinal canal (88.91, 88.93) 7 1.6 24 8.0 29 17.6 60 6.8
Spinal tap (03.31) 4 0.9 10 3.3 5 3.0 19 2.1
Bronchoscopy (33.21) 52 12.3 16 5.3 1 0.6 69 7.7
Open biopsy of soft tissue (83.21) 1 0.2 14 4.6 - - 15 1.6
a ICD-9-CM codes for procedures in any position
b Percutaneous endoscopic gastrostomy
c Percutaneous endoscopic jejunostom
d Magnetic resonance imaging
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The leading procedures were those related to respira-
tory function, in particular MV was performed in one
third of patients, and tracheostomy in more than 20 %,
similarly to [11, 24] or higher than [10] other Italian
studies. We do not have information to quantify the per-
centage of patients who refused tracheostomy or other
procedures.
Only 11.1 % of patients underwent NIV during an
in-hospital stay. The prevalence of NIV was 47.7 % in
another Italian study collecting information from phy-
sicians providing patient care [11]. As hospital admin-
istrative data capture only in-hospital procedures,
information on NIV performed out of hospital is lack-
ing. Our results, therefore, do not represent the over-
all percentage of patients undergoing NIV but only
those receiving it in-hospital. Patients with bulbar on-
set received NIV, MV and tracheostomy less fre-
quently than those with spinal onset, consistently
with other studies [11].
Tracheostomies, MV and in-hospital NIV were per-
formed mostly in emergency non-programmed hospi-
talizations. Respiratory conditions were treated often
in emergency admissions, contrary to recommenda-
tions [5, 6]. This result may indicate poor planning of
respiratory care and highlights an area for improve-
ment of care of ALS patients. Consistently, in a re-
cent study more than two-thirds of tracheostomies
were placed in emergency [25].
Hospitalizations for respiratory failure increased the
risk of in-hospital mortality from more than three-fold
[15] to five-fold [14]. The longitudinal design of our
study, with follow-up performed trough record-linkage
with hospitalization and mortality records, allowed us to
assess the impact of the first hospitalization for respira-
tory failure after the diagnosis of ALS on survival time
and risk of death, including deaths occurred out of
hospital after discharge. After the first hospitalization
for respiratory failure, survival time was 8.0 months
and after the first hospitalization with MV 9.7 months,
shorter than in other population-based Italian studies,
respectively of 19 months (95 % CI, 7–43) [11] and
21 months [10]. The first hospitalization for respira-
tory failure was a strong and independent negative
prognostic factor.
Overall survival
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Fig. 1 Kaplan-Mayer plot with 95 % Hall-Wellnerbands
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The median duration of hospital stay was 8 days, in
line with the results of a prior Italian study (mean
10.3 days) [26] but longer than in a French study (mean
3.3 days) [13]. In the USA, the mean length of stay
varied from 8.4 days [15] to 5 days [14].
Consistently with our results, in-hospital mortality was
not associated with Charlson comorbidity score [14, 15].
In our study, a score ≥ 3 appeared protective. Our results
did not vary substantially when the term for Charlson
Index score was removed from the model. The Charlson
Index assigns the highest weights to conditions such as
malignancies, diabetes with organ damage or moderate
to severe renal disease, and may not capture clinical
conditions that specifically influence the risk of death in
patients with ALS, such as malnutrition [27] or respira-
tory problems. Comorbidities such as coronary heart
disease, history of myocardial infarction, diabetes melli-
tus, seem to have no effect on the survival of ALS
patients [28]. Moreover, these patients had less cardio-
vascular comorbidity and risk factors compared to the
general population [28–30].
Nutritional deficiency occurred only in a small percent-
age of hospitalizations, contrary to other studies [14, 15].
Nutritional procedures and gastro-enterostomies were
performed mostly during elective hospitalizations. Diag-
nostic procedures were most common in day-hospital ad-
missions. These findings suggest that the diagnostic
pathway as well as nutritional support were well planned.
In our study, more than half of deceased patients died
in hospital. This high percentage calls for improved ad-
vance terminal care planning.
In the region FVG, patients with ALS are offered clin-
ical follow-up at the two University Hospitals of the
Region. They are referred to outpatient respiratory
clinics for assessment and follow-up of respiratory con-
ditions. At the time of the study conduct, however, there
was no common regional guideline for respiratory
follow-up and home care nor for timing of initiation and
methods of ventilation. Therefore, the follow-up of ALS
patients was probably not uniform.
Integrated health care provision, including follow-up
and home care of respiratory problems, has improved
patients’ quality of life and optimized hospital utilization,
reducing emergency admissions [13, 17]. Our study
therefore highlighted important areas of improvement in
supportive care of patients with ALS.
Strengths
The main strength of our study is its population-based
and longitudinal design.
This cohort included all incident cases in a well-
defined time period and geographical area. The ascer-
tainment of cases was complete, as suggested by inci-
dence rates within the range of other European registries
[19]. All study subjects were confirmed incident cases of
ALS. Diagnosis was made according to consensus cri-
teria and validated by an expert neurologist.
The probability of emergency gastrostomies varied ac-
cording to ethnicity and health insurance of patients
[25]. Our study was conducted in a universal health care
system. All members of the cohort are residents of FVG
and have the same criteria for access to hospital care,
irrespectively of socio-economical status. The results are
therefore not influenced by differential access to hospital
care.
Hospitalization episodes were obtained from health
administrative databases, an objective source. All epi-
sodes were captured, as the database records all hospi-
talizations occurred in public and private hospitals of
FVG and of other Italian regions.
Limitations
Factors such as living without a partner [31], area of
residency [32], nutritional status at diagnosis or during
the course of disease [33] as well as a diagnosis of fron-
totemporal dementia [31], have an unfavorable prognos-
tic role in ALS. Information on clinical, psychosocial or
environmental factors were not recorded in our data and
we could not assess their role.
As we lack information on preferences of patients and
families, the percentage of patients offered NIV/MV in
Table 4 Relation between mortality, hospitalizations for
respiratory failure and clinical characteristics. Hazard Ratio (HR),
with 95 % Confidence Interval (95 % CI)
Univariate Multivariatea
p HR 95 % CI p HR 95 % CI
Hospitalization for respiratory failure
Nob 1.00 - - 1.00 - -
Yes <0.0001 3.52 2.65; 4.67 <0.0001 4.00 3.00; 5.34
Site of onset
Spinalb 1.00 - - 1.00 - -
Bulbar 0.0005 1.71 1.27; 2.32 0.0791 1.32 0.97; 1.81
Missing 0.0084 1.69 1.14; 2.49 0.2113 1.31 0.86; 2.01
Age (years)
< 68b 1.00 - - 1.00 - -
≥ 68 <0.0001 2.05 1.56; 2.69 <0.0001 2.50 1.86; 3.36
Diagnostic delay
≥medianb, c 1.00 - - 1.00 - -
< medianc 0.0065 1.81 1.18; 2.77 0.0004 2.23 1.43; 3.47
Unknown 0.1095 1.34 0.94; 1.91 0.0459 1.48 1.01; 2.19
a site of onset, age, diagnostic delay
b Reference category
c Median: 276 days
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advance and the percentage of those who accepted could
not be calculated.
Conclusions
In this population-based cohort of patients with ALS,
hospitalizations were very common. Respiratory failure,
pneumonia and aspiration pneumonia were the leading
causes for hospital care utilization. Respiratory condi-
tions were often dealt with in emergency admissions.
Hospitalizations for respiratory failure had a strong inde-
pendent negative effect on survival.
This study identified important areas for improvement
in the care of patients with ALS. Strategies such as
community-based interventions and care may improve
the management of respiratory problems and reduce un-
necessary emergency admissions. Improved advance ter-
minal care planning may reduce the percentage of in-
hospital deaths.
More research is needed to assess the relation between
patients’ characteristics, such as socio-demographic fac-
tors, presence of support or area of residency, and hos-
pital care utilization. Such studies could identify key
factors in designing and implementing interventions
aimed at improving the management of respiratory con-
ditions in patients with ALS.
Additional file
Additional file 1: Table S1. Number and distribution of discharge
diagnoses by type of admission, in hospitalizations ending with death.
Table S2. Relation between mortality, hospitalizations for respiratory
failure and clinical characteristics. Hazard Ratio (HR), with 95 % Confidence
Interval (95 % CI). (DOCX 30 kb)
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